SDH mutations establish a hypermethylator phenotype in paraganglioma. - Wikidata - awgldk - TriplyDB

SDH mutations establish a hypermethylator phenotype in paraganglioma.

SDH mutations establish a hypermethylator phenotype in paraganglioma.

http://www.wikidata.org/entity/Q50960567

about

Clinical significance of T cell metabolic reprogramming in cancer Mitochondrial metabolic remodeling in response to genetic and environmental perturbations Dysregulated metabolism contributes to oncogenesis Succinate Dehydrogenase Loss in Familial Paraganglioma: Biochemistry, Genetics, and Epigenetics Defects in mitochondrial metabolism and cancer Instability of succinate dehydrogenase in SDHD polymorphism connects reactive oxygen species production to nuclear and mitochondrial genomic mutations in yeast IDH1 and IDH2 mutations as novel therapeutic targets: current perspectives Oncometabolites: Unconventional triggers of oncogenic signalling cascades Undercover: gene control by metabolites and metabolic enzymes Epigenetic determinants of metastasis The mitochondrial side of epigenetics Oncometabolites: tailoring our genes Catecholamine metabolism in paraganglioma and pheochromocytoma: similar tumors in different sites?Role of mitochondrial dysfunction in cancer progression Rare germline mutations identified by targeted next-generation sequencing of susceptibility genes in pheochromocytoma and paraganglioma.Current views on cell metabolism in SDHx-related pheochromocytoma and paraganglioma Molecular markers of paragangliomas/pheochromocytomas Metabolic control of the epigenome in systemic Lupus erythematosus.SDHA related tumorigenesis: a new case series and literature review for variant interpretation and pathogenicity.Interplay between epigenetics and metabolism in oncogenesis: mechanisms and therapeutic approaches Mitochondrial Deficiencies in the Predisposition to Paraganglioma Flux balance analysis predicts essential genes in clear cell renal cell carcinoma metabolism.Akt-dependent metabolic reprogramming regulates tumor cell histone acetylation Pheochromocytoma in a Twelve-Year-Old Girl with SDHB-Related Hereditary Paraganglioma-Pheochromocytoma Syndrome.Current approaches and recent developments in the management of head and neck paragangliomas.Krebs cycle metabolite profiling for identification and stratification of pheochromocytomas/paragangliomas due to succinate dehydrogenase deficiency.Oncometabolites: linking altered metabolism with cancer.Pheochromocytoma and paraganglioma: diagnosis, genetics, management, and treatment Whole-exome sequencing identifies MDH2 as a new familial paraganglioma gene.2-Oxoglutarate-dependent dioxygenases are sensors of energy metabolism, oxygen availability, and iron homeostasis: potential role in the regulation of aging process.Metabolic reprogramming and epithelial-to-mesenchymal transition in cancer.Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma.Whole-exome sequencing identifies somatic ATRX mutations in pheochromocytomas and paragangliomas.TET proteins and the control of cytosine demethylation in cancer.Metabolome profiling by HRMAS NMR spectroscopy of pheochromocytomas and paragangliomas detects SDH deficiency: clinical and pathophysiological implications.A new specific succinate-glutamate metabolomic hallmark in SDHx-related paragangliomas.A novel microscopy-based high-throughput screening method to identify proteins that regulate global histone modification levels.Succinate dehydrogenase inhibition leads to epithelial-mesenchymal transition and reprogrammed carbon metabolism.Multi-omics analysis defines core genomic alterations in pheochromocytomas and paragangliomas.Vascular pattern analysis for the prediction of clinical behaviour in pheochromocytomas and paragangliomas.

P2860

Q26741974-DE4B5906-D78F-4F04-83E6-DE65AA749362 Q26747718-FD9FB639-7DDB-429A-BAB1-D0D19B3098AB Q26784630-C460764F-5B22-4DED-9F32-A8FF1406BE74 Q26796203-160FB8B4-7932-4192-817A-B533D2515556 Q27694117-CF7F7067-797A-424A-84A9-87D3A38DF52F Q27938745-7A3F18C6-1C22-429D-AAD1-C1708504CA7B Q28066926-0B6B5DAB-A04A-4D0E-8E1C-CF643192CB33 Q28069594-CC2856ED-C85C-40F5-A8FE-6977C4AF28DA Q28072281-BA067656-08DF-465E-A104-12648CAAF83B Q28079377-E70CD18A-AAE1-40FF-9270-0972C8C3F81B Q28081686-539387C6-2868-4DB2-86AA-F15C2665F5A0 Q28085392-01C34ABE-344C-43E7-B3AB-C452BF27FB20 Q28547046-9C489E52-2419-40F8-89BF-6C53764BB7F7 Q28829644-A7EE0741-D5EC-4B44-9619-43D6477BAEA4 Q33570108-C290AA3C-547D-490B-8308-23B6CCDFE75A Q33590969-9A94A09C-141F-475B-95EA-E9C0C7757A60 Q33649025-E1D6ACA0-87EB-48E4-9A86-513CC9969670 Q33664849-3675579D-0477-4E00-BC95-C60BC59C4D20 Q33718501-0BD0222F-95C9-4227-809E-20560137B6C2 Q33835913-A4DDDB15-D3AE-493C-ADE9-684EF68BD0B3 Q33844924-B3392EDD-2957-419C-AE83-05B804F3C355 Q34044149-9C52ECA4-6D35-414C-B11C-842763640C06 Q34117812-47AF3862-9164-4878-9B49-FC9563B7ED18 Q34145968-D514EDC4-2201-4AAA-A9AB-D12E814C4358 Q34204524-ABB65273-F155-4B03-9CF1-E6AC0AB8CE60 Q34284740-4E7A06B6-3A4D-4990-903E-90AD4FE3E50E Q34368256-FA1734BE-E6B1-4AEB-9F12-6F560190EF73 Q34410500-B97A579A-0562-458A-A60C-5320EDB9173E Q34466932-EBAC8C72-E17C-45C9-AC94-1F1F69CF1CDD Q34482634-7D908105-6792-42FC-B246-8F0D53B55B29 Q34555855-99E82EB6-4CE5-41B1-9AB5-77741E2A509B Q34680693-422C34F4-4B1B-4EA2-B35E-D9A6BB1A7097 Q34998940-5180F97D-7116-4A00-8C37-4760BD4CFA92 Q35021377-43C50952-616F-4C61-AA08-1B4A2DE518EB Q35024067-DE6DD8D5-873F-40DD-9CBF-BF311C80B8F5 Q35060334-0643A5D7-76CE-4500-A6BC-6AF6D1BFA44F Q35066149-20566FC7-28DC-49A3-84EF-5CDD045D1C8E Q35067274-D1A27181-EC23-4957-ABE3-AFDE30F475AA Q35160825-7A30C9EF-F5B8-4FCC-AD64-DF62FD8ED3C4 Q35203161-0093D083-05B8-4826-9505-11F400E7A1AE

P2860

SDH mutations establish a hypermethylator phenotype in paraganglioma.

http://www.wikidata.org/entity/Q50960567

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

SDH mutations establish a hypermethylator phenotype in paraganglioma.

@en

SDH mutations establish a hypermethylator phenotype in paraganglioma.

@nl

type

label

SDH mutations establish a hypermethylator phenotype in paraganglioma.

@en

SDH mutations establish a hypermethylator phenotype in paraganglioma.

@nl

prefLabel

SDH mutations establish a hypermethylator phenotype in paraganglioma.

@en

SDH mutations establish a hypermethylator phenotype in paraganglioma.

@nl

P1433

Q50960567-A9CABB78-1D54-4CB5-B522-A1CC0BA70A77

P1476

Q50960567-F777FFBC-BB59-4272-BCEF-2FBA3FA3ED0F

P2093

Q50960567-213A99D5-FF28-479C-82BE-AE783B0FC5C9

Q50960567-43EF7E76-8A6A-4CEC-8D3B-6A7DE637CC83

Q50960567-5278C638-EAC1-4B24-9A77-954A28AC86AC

Q50960567-7DF1DF4F-51F2-480C-811F-2428B88DF91A

Q50960567-8D77A6EC-358D-4B2D-B531-A3AD54E33F8F

Q50960567-A3E01E04-4CAC-4481-BDE7-DD473C8FEF38

Q50960567-B7D35F38-0A6D-4FBA-A3A2-FF2B7CA5ABC1

Q50960567-C1FD0385-B116-4C7D-A988-AAAFA125D755

Q50960567-C7DF3B98-A345-4F62-9128-00E514D2C4FE

Q50960567-C89E756E-818E-4AF5-95B7-116748A075C1

P304

Q50960567-BEFFAF5B-758C-4DA9-AC34-838D067388CA

P31

Q50960567-CB547557-4365-4E8B-B85B-B1FF9E4A1317

P356

Q50960567-DB3EE689-F86C-4C6A-9100-21749FA559DB

P433

Q50960567-919A396C-4550-4E8F-9DF6-CED68B4D4581

P478

Q50960567-5F0A965B-AEAB-4BAC-B290-9211B7517660

P50

Q50960567-2390D7E8-DABD-45F0-BE74-376DF711A8FC

Q50960567-3283F3CE-E5DC-4CE9-A510-37939E0E9BC3

Q50960567-373AF65E-1362-4CCD-ACA3-762E593217D4

Q50960567-3EF86F15-11BB-4F61-8018-6923D1877696

Q50960567-455A4BF6-84B6-47D9-B363-CF7F4E1078E2

Q50960567-785248F4-20E5-47D3-BC4D-623618660250

P577

Q50960567-D4C40B3A-EDF9-45AC-A2F4-4663FD5F3057

P5875

Q50960567-0DD4706D-AD1B-4740-B707-D46ECDB5082A

P698

Q50960567-1EF58183-D19D-4FFF-A3AF-BDD3B8E33569

P356

J.CCR.2013.04.018

P1433

P1476

SDH mutations establish a hypermethylator phenotype in paraganglioma

@en

P2093

Alexandre Buffet

http://www.w3.org/2001/XMLSchema#string

An Thach Nguyen

http://www.w3.org/2001/XMLSchema#string

Aurélien De Reyniès

http://www.w3.org/2001/XMLSchema#string

Charles Marcaillou

http://www.w3.org/2001/XMLSchema#string

Chris Ottolenghi

http://www.w3.org/2001/XMLSchema#string

Cosimo Martinelli

http://www.w3.org/2001/XMLSchema#string

Céline Loriot

http://www.w3.org/2001/XMLSchema#string

Mélanie Menara

http://www.w3.org/2001/XMLSchema#string

Nasséra Abermil

http://www.w3.org/2001/XMLSchema#string

Nelly Burnichon

http://www.w3.org/2001/XMLSchema#string

P304

739-752

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CCR.2013.04.018

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

23

http://www.w3.org/2001/XMLSchema#string

P50

Jérome Bertherat

Anne-Paule Gimenez-Roqueplo

P577

2013-05-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236938926

http://www.w3.org/2001/XMLSchema#string

P698

23707781

http://www.w3.org/2001/XMLSchema#string